Cibus (CBUS) Finished Goods (2019 - 2020)
Cibus (CBUS) posted Finished Goods of $1.5 million for Q3 2020, up 275.93% sequentially from $403000.0 in Q2 2020, and up 3687.5% YoY from $40000.0 in Q4 2019.
Cibus (CBUS) Finished Goods (2019 - 2020) Analysis & Trends
Cibus has reported Finished Goods for 2 years, with the latest figure at $1.5 million in Q3 2020.
- Quarterly Finished Goods rose 3687.5% year-over-year to $1.5 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $1.5 million (up 3687.5% YoY) and the FY2019 annual result came in at $111000.0, changed N/A from the prior year.
- Finished Goods grew to $1.5 million in Q3 2020 per CBUS's latest filing, from $403000.0 in the prior quarter.
- Over five years, Finished Goods peaked at $1.5 million in Q3 2020 and troughed at $14000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Cibus | 135.09 Mn | 114.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 403,000.00 |
| Mar 31, 2020 | 218,000.00 |
| Dec 31, 2019 | 111,000.00 |
| Sep 30, 2019 | 40,000.00 |
| Jun 30, 2019 | 14,000.00 |